Aurinia Pharmaceuticals I... (AUPH)
NASDAQ: AUPH
· Real-Time Price · USD
12.27
0.18 (1.49%)
At close: Aug 15, 2025, 3:59 PM
12.44
1.43%
After-hours: Aug 15, 2025, 07:44 PM EDT
Aurinia Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 260.11M | 247.29M | 235.13M | 220.36M | 207.1M | 191.41M | 175.51M | 158.85M | 160.12M | 146.81M | 134.03M | 129M | 87.89M | 66.32M | 45.6M | 72.23M | 57.59M | 51M |
Cost of Revenue | 27.28M | 29.07M | 28.25M | 28.09M | 28.82M | 21.48M | 14.15M | 10.12M | 5.79M | 5.83M | 5.66M | 4.78M | 2.59M | 1.3M | 1.09M | 13.78M | 18.33M | 29.1M |
Gross Profit | 232.84M | 218.22M | 206.88M | 192.27M | 178.28M | 169.93M | 161.37M | 148.74M | 154.32M | 140.99M | 128.37M | 124.22M | 85.3M | 65.02M | 44.51M | 58.45M | 39.26M | 21.91M |
Operating Income | 52.01M | 31.2M | -1.35M | -20.28M | -48.29M | -63.73M | -82.62M | -90.12M | -83.35M | -103.17M | -111.47M | -116.08M | -156.93M | -168.07M | -180.74M | -156.08M | -142.07M | -121.8M |
Interest Income | 15.01M | 16.01M | 16.97M | 17.55M | 17.8M | 17.71M | 17M | 15.34M | 12.29M | 8.67M | 5.12M | 2.32M | 960K | 619K | 529K | 555K | 619K | 798K |
Pretax Income | 62.48M | 41.81M | 7.45M | -20.14M | -48.1M | -61.71M | -77.47M | -76.24M | -71.13M | -94.5M | -106.35M | -113.76M | -155.97M | -167.46M | -180.21M | -155.53M | -139.38M | -121.89M |
Net Income | 60.64M | 39.84M | 5.75M | -22.55M | -50.35M | -62.56M | -78.02M | -77.19M | -72.73M | -96.76M | -108.18M | -115.46M | -156.72M | -168.22M | -180.97M | -155.72M | -139.53M | -122.04M |
Selling & General & Admin | 123.03M | 141.94M | 169.3M | 182.34M | 190.46M | 192.61M | 195.04M | 192.44M | 196.85M | 201.3M | 196.37M | 193.14M | 185.1M | 177.35M | 171.44M | 165.97M | 152.91M | 124.67M |
Research & Development | 24.33M | 20.98M | 20.79M | 22.91M | 33.46M | 42.03M | 49.64M | 49.28M | 46.65M | 45.53M | 44.99M | 46.27M | 55.36M | 53.93M | 51.14M | 53.16M | 37.9M | 38.88M |
Other Expenses | 25.24M | 15.88M | 9.92M | 7.3M | 2.65M | 2.65M | 2.94M | 765K | -2.19M | -2.67M | -1.52M | 884K | 1.77M | 1.81M | -1.39M | -7.37M | -8.24M | -7.53M |
Operating Expenses | 180.83M | 187.03M | 208.23M | 212.55M | 226.57M | 233.66M | 243.98M | 238.85M | 237.68M | 244.16M | 239.84M | 240.29M | 242.23M | 233.09M | 223.48M | 220.19M | 191.79M | 165.46M |
Interest Expense | 4.54M | 4.62M | 4.83M | 5M | 5.19M | 4.06M | 2.77M | 1.47M | 65K | n/a | n/a | n/a | n/a | n/a | n/a | 339K | 440K | 518K |
Selling & Marketing Expenses | 14.94M | 16.75M | 19.59M | 5.5M | 5.5M | 2.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 208.1M | 216.1M | 236.48M | 240.64M | 255.39M | 255.13M | 258.13M | 248.97M | 243.47M | 249.99M | 245.5M | 245.07M | 244.82M | 234.39M | 224.57M | 220.8M | 192.15M | 165.5M |
Income Tax Expense | 1.85M | 1.96M | 1.7M | 2.41M | 2.25M | 854K | 551K | 947K | 1.6M | 2.25M | 1.83M | 1.7M | 753K | 762K | 760K | 191K | 148K | 152K |
Shares Outstanding (Basic) | 138.92M | 138.92M | 142.18M | 143.05M | 143.33M | 144.01M | 143.83M | 142.85M | 142.78M | 142.64M | 142.27M | 141.86M | 141.73M | 139.37M | 130.69M | 128.44M | 128.22M | 127.4M |
Shares Outstanding (Diluted) | 143.2M | 143.2M | 147.68M | 145.65M | 144.11M | 144.01M | 143.83M | 142.85M | 142.78M | 142.64M | 142.27M | 141.86M | 141.73M | 141.68M | 132.05M | 128.44M | 128.22M | 127.4M |
EPS (Basic) | 0.43 | 0.29 | 0.04 | -0.16 | -0.35 | -0.44 | -0.54 | -0.53 | -0.5 | -0.67 | -0.76 | -0.83 | -1.16 | -1.28 | -1.41 | -1.22 | -1.11 | -1 |
EPS (Diluted) | 0.42 | 0.27 | 0.04 | -0.16 | -0.35 | -0.44 | -0.54 | -0.53 | -0.5 | -0.67 | -0.76 | -0.83 | -1.16 | -1.28 | -1.41 | -1.22 | -1.11 | -1 |
EBITDA | 86.5M | 62.76M | 28.61M | 1.27M | -25.93M | -41.68M | -62.85M | -70.58M | -71.51M | -94.67M | -106.4M | -110.5M | -152.94M | -164.86M | -177.93M | -159.18M | -151.48M | -131.59M |
EBIT | 67.02M | 46.43M | 12.28M | -15.14M | -42.91M | -57.65M | -74.69M | -77.69M | -73.97M | -97.41M | -109.52M | -114.13M | -156.45M | -168.07M | -180.74M | -161.25M | -153.21M | -132.94M |
Depreciation & Amortization | 19.48M | 19.45M | 19.45M | 19.53M | 20.09M | 15.97M | 11.84M | 7.11M | 2.46M | 2.74M | 2.86M | 3.33M | 3.23M | 2.98M | 2.83M | 2.53M | 2.31M | 2.07M |